MedPath
FDA Approval

Mupirocin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 8, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Mupirocin(2 g in 100 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Encube Ethicals Private Limited

Encube Ethicals Private Limited

725076298

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mupirocin

Product Details

NDC Product Code
21922-029
Application Number
ANDA213076
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
August 31, 2021
GLYCERYL MONO AND DIPALMITOSTEARATEInactive
Code: KC98RO82HJClass: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACT
POLYOXYL 20 CETOSTEARYL ETHERInactive
Code: YRC528SWUYClass: IACT
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
PHENOXYETHANOLInactive
Code: HIE492ZZ3TClass: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
MupirocinActive
Code: RG38I2P540Class: ACTIMQuantity: 2 g in 100 g
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath